Background: chronic infection with hepatitis B virus (HBV) is a major risk factor for liver cirrhosis and hepatocellular carcinoma (HCC). Programmed death-1 (PD-1) has been involved in regulating immune responses to viral infections and tumors and has a critical role in HBV infection. Objectives: to investigate the effect of PD1 (+8669 G/A) single-nucleotide polymorphism (SNP) on disease susceptibility and progression of chronic HBV infection in Egyptian patients. Methodology: Blood samples were taken from 70 patients with confirmed chronic hepatitis B (CHB), HBV-related liver cirrhosis (LC) or HCC on top of HBV infection and 25 healthy controls. Genotyping of PD1 (+8669 G/A) polymorphism was studied using bidirectional PCR amplification of specific alleles (Bi-PASA).Results: A significantly higher frequency of PD-1 (+8669 G/A) AA genotype and A allele was found in CHB group (36.8 %) and LC group (21.7%) compared to control group (0.0%) (P< 0.05). On the other hand, the GG genotype and G allele were over represented in healthy controls (72.7%) than CHB group (52.6%) and LC group (47.8%). In assessing the risk of susceptibility to infection with HBV, The G allele was significantly predominant in healthy subjects compared to hepatitis B patients (89.4% versus 68.5%) (P< 0.05). G allele was markedly increased with disease progression to HCC (P = 0.006). Conclusion: Our study suggested that PD1 (+8669) polymorphism has significantly implicated in the disease susceptibility with AA genotype and A allele as a predisposing and the GG genotype and G allele as a preventive factors for chronic HBV infection. Also this study revealed a significant effect of the PD1 (+8669) polymorphism in the progression to HCC in hepatitis B patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.